Coronavirus impact: Aim’s healthcare companies firmly in favour
The quest to find a test, treatment or vaccine for coronavirus is heating up. Academics and companies have shifted resources away from traditional operations to fight the Covid-19 battle and identify solutions which could make a big difference to how the UK deals with the illness. Successful companies are likely to enjoy an enormous boost amid the demand of a population under siege.
The challenges posed by Covid-19 could provide a big turning point for the UK's small pharma industry which has languished for several years as the plethora of companies which listed around 2015 have struggled to commercialise treatments. Now money is flowing freely into the market as it tries to battle the pandemic - healthcare is key to reducing the human and financial catastrophe of coronavirus.
Abcam: supporting its customers
Abcam (AIM: ABC), the global leader in the supply of life science research tools and one of AIM’s largest companies, has issued a much anticipated coronavirus update. Many of Abcam’s customers are directly engaged in the effort to develop diagnostic tests, vaccines and treatments for Covid-19.
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on 4D Pharma
Coronavirus impact: Aim’s healthcare companies firmly in favour
The quest to find a test, treatment or vaccine for coronavirus is heating up. Academics and companies…
Who should you follow in the IPO lottery?
With 2014 seeing the highest number of new admissions to AIM since the glory days of…
More on Abcam
AIM new arrivals and leavers November
While the AIM index rose, it was another poor month for newcomers on AIM. December will…
Coronavirus impact: 22 Oct - several terrific updates here
We are really impressed with the excellent trading updates from several companies featured here, which highlight…
More on Genedrive
Coronavirus impact: 22 May - more fund raises for the desperate and thriving
Two companies exposed to the leisure and entertainment markets successfully raised new money to see them…
Bonkers valuations for anything remotely connected to Covid-19
The share price of a small investment group soared on news that one its portfolio companies…
More on Omega Diagnostics Group
Coronavirus impact: 27 April - more healthcare winners and even some dividends
It was another positive day for small healthcare companies, particularly those providing tests for Covid-19, however,…
Coronavirus impact: Aim’s healthcare companies firmly in favour
The quest to find a test, treatment or vaccine for coronavirus is heating up. Academics and companies…
More on Renalytix AI PLC
Coronavirus impact: Aim’s healthcare companies firmly in favour
The quest to find a test, treatment or vaccine for coronavirus is heating up. Academics and companies…
November 2018: AIM new arrivals - AIM sinks below £100bn value
November 2018 saw a continuation of the AIM sell-off, with few places to hide and AIM’s…
More on Sensyne Health PLC
Sensyne gets its dosh | Valuations!
This innovative med tech company has secured much needed funding to get it through the sale…
An unhealthy share price reaction
The share price of Sensyne Health has dived following a disappointing trading update suggesting its survival…
More on Yourgene Health
Big acquisition premium | Agricultural challenges | Suspensions
News covered in our free update here includes results from a well-established supplier of agricultural products,…
Coronavirus impact: Aim’s healthcare companies firmly in favour
The quest to find a test, treatment or vaccine for coronavirus is heating up. Academics and companies…
